China Bionanometer Industries Corporation (Pink Sheets: CBIU - News), a leading company within the bionanometer industry, will soon introduce new products in 2008 after nearly one year of scientific verification, research and experiments, on the prevention and treatment of influenza -- the "Anti-influenza Oral Granules" and the "Influenza Partner."
Influenza is an eternal and worldwide topic. Vaccination is one preventive approach, and through many Chinese herbs the effect of prevention can be achieved. The Company will introduce influenza prevention granules in 2008 that will be better than the "Banlangen Granules" most frequently used at this time.
Patients that suffer from influenza despite the use of anti-viral medications could suffer injury, in particular to the liver and the kidneys. Many Chinese medicinal products can protect and restore damaged livers and kidneys. These new products have received government approval and can be applied to prevention and recovery treatment of influenza.
The CEO of the company, Mr. Chen Min, stated, "With the successful promotion of these new products, we believe that we will benefit greatly from this newly discovered market and will surely have a prosperous outcome. "
About China Bionanometer Industries Corporation
China Bionanometer Industries Corporation is a high-tech enterprise specializing in the research, development, production and sale of nanometer level health food, cosmetics, biological disinfection products, and traditional Chinese medicine, etc. The company has obtained the state authentication for high and new technology enterprises and is also an academician enterprise in the high-tech field.
As a high and new technology enterprise that takes scientific research as its base, profiting from the huge benefits brought by technological innovation, the Company establishes an efficient scientific research development system that allows the continuation of the pursuit for newer technologies and industrial development by creating a people-oriented and innovative environment that follows the modern management model.
Forward-looking Statement
Certain information contained in these materials is "forward-looking" information, such as projections, estimates, pro formas, or statements of intentions, expectations or plans.
All forward-looking information is subject to known and unknown risks and uncertainties, many of which are outside of the control of the Company. Consequently, actual results may, and probably will, differ materially from the results contemplated in such forward-looking information.
Disclaimer: This profile has been compiled by Elite Equity Marketing based on information believed to be true. This profile is not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company’s periodic filings with the Securities and Exchange Commission. Elite Equity Marketing has received sixty three thousand five hundred dollars from a third party, who may be selling shares in CBIU, for investor relations services rendered, including this profile. From time to time, we will hold a position in and trade in (buy/sell) in CBIU. This is not a solicitation to buy or sell securities
Source: China Bionanometer Industries Corporation
